Summary
Sandra Zhong is a multidisciplinary executive and founder with a decade of experience building companies and ecosystems at the intersection of neuromodulation, biotech, and translational medicine. As CEO of AscenZion and Suzhou YiXinKang, Executive Chair at Yiqi Biotechnology, and VP Asia for the Eureka Institute, she leads commercialization of non-invasive neurotherapies for chronic neurological and psychiatric disorders while also chairing nonprofit efforts to improve care for special-needs children. Her background spans neuroscience (MSc Applied Neuroscience, Harvard training), finance (senior roles at Deutsche Bank and Credit Suisse), and business (MBA), enabling her to bridge clinical science, product strategy, and capital formation. Based in Singapore, she combines hands-on technical curiosity—evident in a parallel interest as a web3 full‑stack developer—with a track record of building cross-border research and philanthropic initiatives.
10 years of coding experience
9 years of employment as a software developer
Harvard T.H. Chan School of Public Health
GCE A levels, GCE A levels at Raffles Junior College
Bachelor's degree, Accounting, Bachelor's degree, Accounting at Nanyang Technological University Singapore
Master of Business Administration - MBA, Master of Business Administration - MBA at Cheung Kong Graduate School of Business
MSc Applied Neuroscience, Neuroscience, MSc Applied Neuroscience, Neuroscience at King's College London
Political Science and Government, Political Science and Government at 清华大学经济管理学院 Tsinghua University School of Economics and Management